Discover trends, market shifts, and competitive outlooks for the liver cancer diagnostics industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research
How Has the Liver Cancer Diagnostics Market Growth Performance Trended Historically, And What Lies Ahead?
In recent times, the liver cancer diagnostics market has experienced significant growth. The market size, which was at $9.69 billion in 2024, is projected to increase to $10.4 billion in 2025, reflecting a compound annual growth rate (CAGR) of 7.3%. Progress in biopsy tactics and histopathology, innovations in biomarker identification, the enhancement of screening initiatives, advancement in genetic testing, and developments in liver imaging modalities can all be credited for the growth witnessed in the historical phase.
The market for liver cancer diagnostics is anticipated to experience significant expansion in the upcoming years, projected to reach “$13.86 billion by 2029, with a compound annual growth rate (CAGR) of 7.4%. Factors contributing to this growth during the forecast period include regulatory shifts and standardization, increased emphasis on imaging modalities, advancements in next-generation sequencing, wider screening programs and public awareness, and a greater need for biomarker-based tests. Key trends during the forecast period include a surge in incidents and prevalence, innovations in imaging technologies, a shift towards non-invasive diagnostic methods, individualized and precision medicine, and the incorporation of artificial intelligence (AI).
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10481&type=smp
What Are the Core Growth Drivers Propelling the Liver Cancer Diagnostics Market Forward?
The increasing incidence of liver cancer is anticipated to spur the expansion of the liver cancer diagnostics market. Liver cancer involves unrestricted growth and replication of liver cells that ultimately culminates in a lethal disease. Diagnostic tests for liver cancer are conducted to identify if the cancer cells are proliferating within the liver or extending beyond it, after primary liver carcinoma’s diagnosis. Hence, the increasing incidence of liver cancer fuels the liver cancer diagnostics market’s growth. For example, in January 2023, the Cancer Facts & Figures 2023 report by the American Cancer Society, a US-based voluntary health organization, stated that the new liver and intrahepatic bile duct cancer cases among females climbed to 13,230 in 2023 from 12,640 in 2020 in the USA. Additionally, in 2023, it was projected that 41,210 new liver cancer cases will get diagnosed in the US, with a predicted fatality of 29,380 individuals. Therefore, the increasing prevalence of liver cancer is propelling the expansion of the liver cancer diagnostic market.
What Segment Types Define the Liver Cancer Diagnostics Market Structure?
The liver cancer diagnostics market covered in this report is segmented –
1) By Type: Hepatocellular Carcinoma, Cholangiocarcinoma, Hepatoblastoma, Other Types
2) By Screening: Laboratory Testing, Imaging, Endoscopy, Biopsy, Other Screenings
3) By Technology: Fluorescent In Situ Hybridization (FISH), Comparative Genomic Hybridization (CGH), Immunohistochemical (IHC), Other Technologies
4) By End Use: Hospitals And Diagnostic Laboratories, Academic And Research Institutes, Pharmaceutical And CRO Laboratories
Subsegments:
1) By Hepatocellular Carcinoma: Early-Stage Hepatocellular Carcinoma, Advanced-Stage Hepatocellular Carcinoma
2) By Cholangiocarcinoma: Intrahepatic Cholangiocarcinoma, Extrahepatic Cholangiocarcinoma
3) By Hepatoblastoma: Pure Hepatoblastoma, Mixed Hepatoblastoma
4) Other Types: Secondary Liver Cancer, Fibrolamellar Carcinoma
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=10481&type=smp
Which Geographic Areas Hold the Strongest Growth Potential in the Liver Cancer Diagnostics Market?
North America was the largest region in the liver cancer diagnostics market in 2024. The regions covered in the liver cancer diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Which Emerging Trends that Are Influencing theLiver Cancer Diagnostics Industry Evolution?
Leading firms within the liver cancer diagnostics market are innovating with cutting-edge biomarker-based assays and algorithms to enhance diagnostic precision and facilitate early detection. These diagnostic instruments use specific biological markers to recognize diseases, thus offering more accurate and efficient diagnosis. For instance, Roche Diagnostics, an American biotech firm, introduced the Elecsys PIVKA-II assay and Elecsys GAAD algorithm in November 2023. The Elecsys PIVKA-II assay recognizes heightened levels of the PIVKA-II biomarker, linked to hepatocellular carcinoma (HCC), thereby enhancing early liver cancer detection in patients at high risk. Meanwhile, the Elecsys GAAD algorithm amalgamates various diagnostic markers, like PIVKA-II and AFP to boost diagnostic accuracy and make the process of liver cancer detection more efficient.
View the full report here:
https://www.thebusinessresearchcompany.com/report/liver-cancer-diagnostics-global-market-report
What Is the Definition of the Liver Cancer Diagnostics Market?
Liver cancer diagnostics refers to the various methods employed to detect and diagnose liver cancer, a type of cancer that originates in the liver. It is used for the early detection and diagnosis of liver cancer via imaging and molecular testing.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10481
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
